In our article “Too little, too late” in last week’s issue, we stated that Dr. Adam Fein, founder and CEO of Drug Channel Institute and publisher of DrugChannels, has pharmacy benefit managers (PBMs) as clients. According to Dr. Fein, that is incorrect. As stated on DCI’s website: “Dr. Fein’s work with healthcare products manufacturers precludes him from any business consulting assignments with wholesalers, distributors, pharmacy benefit managers, and dispensers of healthcare products and pharmaceuticals.” And PBMs have not advertised on Drug Channels, according to Dr. Fein.

We called a statement of support from a reader from PBM Express Scripts management an “endorsement.” Dr. Fein calls it is a testimonial.

We referred to DrugChannel readers as “subscribers” because the DCI website refers to its readers as ‘subscribers.” According to Dr. Fein, there is no fee for a subscription to DrugChannels. “We use the term ‘subscriber’ to distinguish people who subscribe via email vs. those who follow me/Drug Channels on Twitter and LinkedIn,” explained Dr. Fein in an April 14 email.